Low- and middle-income countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological manufacturing in their regions. Establishing such manufacturing capacity, through bilateral technology transfer or through local R&D efforts is frequently hampered by the lack of a workforce trained in biomanufacturing.
To address this gap and to build biomanufacturing capacity in LMICs, the World Health Organization (WHO) and the Ministry of Health and Welfare of the Republic of Korea (MoHWK) are working towards establishing the first of its kind Global Training Hub for Biomanufacturing (GTH-B).
The hub is mandated to provide training in manufacturing of high-quality vaccines and biologics in an industrial setting to resolve inequality in access to vaccines and biologics worldwide by expanding manufacturing capacity in LMICs.
In 2022, two training courses, Introductory course for biologics development & manufacturing and Introductory course for global standards (GxP) were organized by the International Vaccine Institute (IVI) in Seoul, South Korea for about 330 participants from more than 30 LMICs.
For the second year, the Republic of Korea in agreement with WHO is organizing a new training operated by IVI focusing on introduction to biologics development & manufacturing in June 2023 for 120 trainees from LMICs.